< Back to Federal Health Update Archives

FEDERAL HEALTH UPDATE

October 5, 2007

Produced by Kate Connelly Theroux in collaboration with the U.S. Medicine Institute for Health Studies (USMI)

To subscribe, please visit http://usminstitute.org/subscriber.cfm.

Sponsored by

Additional sponsorship by

Menu

Congressional Schedule

On Oct. 1, 2007, the Senate passed H.R. 1585, as Amended, the National Defense Authorization Act for Fiscal Year 2008. 

On Oct. 3, 2007, President Bush vetoed H.R. 976, the Children’s Health Insurance Program (SCHIP) Reauthorization Act.  This legislation would have reauthorized SCHIP and expanded enrollment in the program to about 10 million children.

The Senate passed H.R. 3222, Department of Defense Appropriations Act, 2008, on Oct. 3, 2007.  The $459.6 billion bill now goes to conference to resolve the differences with the House version.

On Oct. 4, 2007, Senator Pete Domenici, (R-N.M.) announced that he is retiring at the end of his sixth term because of a degenerative brain disease, frontotemporal lobar degeneration, or FLTD.  He will complete his term in January 2009.

Sen. Larry Craig (R-Idaho) announced on Oct. 4, 2007 that despite a judge's refusal to allow him to withdraw his guilty plea, he would serve out the rest of his term in the Senate but not seek re-election in 2008.

Back to Top

Military Health Care News

TRICARE Management Activity published a notice in the Federal Register, which provides the updated per diem rates for FY 2008 under the TRICARE Mental Health Per Diem Payment System; and the updated per diem rates for both full-day and half-day TRICARE Partial Hospitalization Programs for FY 2008.  The FY 2008 rates contained in this notice are effective for services occurring on or after Oct. 1, 2007.

On Oct. 2, 2007, the Department of Defense announced that President Bush has nominated Army Maj. Gen. Eric B. Schoomaker for appointment to the rank of lieutenant general and assignment as commanding general, U.S. Army Medical Command/Surgeon General, U.S. Army, Falls Church, Va. He is currently serving as the commanding general, North Atlantic Regional Medical Command/Walter Reed Army Medical Center, Washington, D.C.

The Department of Defense announced that Maj. Gen. Carla G. Hawley-Bowland will be assigned to be commanding general, North Atlantic Regional Medical Command/Walter Reed Army Medical Center, Washington, D.C. She is currently commanding general, Tripler Army Medical Center/Pacific Regional Medical Command/U.S. Army Pacific surgeon/lead agent, Tricare Pacific/chief, U.S. Army Medical Corps, Honolulu, Hawaii.

The Military Health System (MHS) launched a new Web site, which leverages Web 2.0 technology.  The new Web site allows military and civilian health care professionals to submit questions, share ideas and recognize peers – interactively.  It also gives the public an opportunity to keep informed and comment on the status of the MHS.

The new Web site includes a “blog” located off of the main page where Assistant Secretary of Defense for Health Affairs Dr. S. Ward Casscells engages in an open discussion about military medicine. Readers can leave comments at the end of each daily entry.

Another feature, called Pulse Check, will ask questions about the MHS. The answers will be used to make improvements and inform others about decision-making processes. There are also areas for feedback to recognize people for making that “extra effort,” or for visitors to let leadership know if they aren’t getting the entire story.

Defense officials anticipate future innovations like a new MHS motto, logo and theme song that will be designed from the suggestions and feedback of visitors to the Web site. http://www.tricare.mil/pressroom/news.aspx?fid=322

The U.S. Medicine Institute posted its executive summary of a recent roundtable discussion: “TBI: Fitting the Pieces Together.”  The roundtable focused on issues surrounding diagnosing and treating traumatic brain injury (TBI).  During the discussion, representatives from federal agencies, congressional offices, academia and professional and beneficiary organizations agreed on the need for improved collaboration to make maximum use of resources and to help wounded soldiers and their families.  http://www.usminstitute.org/

Health Net Federal Services LLC has been recognized for call center operation customer satisfaction excellence under the J.D. Power and Associates Certified Call Center Program(SM).

Through the TRICARE program, the Health Net Federal Services' call center handles more than 4.2 million customer interactions per year. Health Net Federal Services' call center operations successfully passed a detailed audit of their recruiting, training, employee incentives, management roles and responsibilities, and quality assurance capabilities. As part of its evaluation, J.D. Power and Associates conducted a random survey of TRICARE beneficiaries and providers who recently contacted its call centers. TRICARE is the uniformed services health care program for active duty, retired, Guard and Reserve, and their families provided through the Department of Defense.

For certification status, a call center must also perform within the top 20 percent of customer service scores, which is based on benchmarks established in J.D. Power and Associates' cross-industry customer satisfaction research. The criteria used include evaluation of: courtesy; knowledge; concern for the customer; usefulness of the information provided; convenience of operating hours; ease of reaching a representative; and timely resolution.

The Call Center Certification Program was launched by J.D. Power and Associates in 2004 to evaluate overall customer satisfaction with call centers and to help call centers in various industries increase their efficiency and effectiveness by establishing best practices for handling service calls. http://money.cnn.com/news/newsfeeds/articles/prnewswire/LATH06904102007-1.htm

The DoD Task Force on the Future of Military Health Care held a public meeting on Oct. 3, 2007.  The task force focused on military-to-civilian conversion issues. Mr. Frank Camm, RAND National Defense Research Institute, outlined the research RAND has conducted on how the Services should examine their billets and determine their status. Representatives from the Army, Navy and Air Force testified on the strategies being used to determine what the correct ratio of military and civilian personnel will be most effective and how each of the Services are implementing the conversions. 

The task force also heard testimony about the issues that healthcare systems nationwide face as the population ages and what steps are needed to ensure uniform quality care is delivered.  Dr. Richard Migliori, executive vice president, Business Initiatives and Clinical Affairs, UnitedHealth Group, suggested that more preventative care and disease management programs be used for patients with chronic illnesses.  He also recommended improving communication and records sharing between doctors to alleviate some of the fragmentation and confusion.

The task force ended the meeting hearing from Mr. Steve Lillie, deputy chief, TRICARE Operations; and Mr. Robert Moss, deputy director Management Control and Financial Studies, TRICARE Management Activity about the history, funding and status of the TRICARE For Life program.

Back to Top

Veterans Health Care News

The Department of Veterans Affairs (VA) announced Deputy Secretary of Veterans Affairs Gordon H. Mansfield will become the Acting Secretary of Veterans Affairs following the resignation of Secretary R. James Nicholson on Oct. 1, 2007.

The Senate Veterans Affairs Committee approved the nomination of Paul J. Hutter to be the next General Counsel of the U.S. Department of Veterans Affairs.  The nomination now moves to the floor of the U.S. Senate for final confirmation.

On Oct. 3, 2007, the Veterans Disability Benefits Commission released its final report: Honoring the Call to Duty:  Veterans’ Disability Benefits in the 21st Century.  The report provides 113 recommendations that would help to ensure that the benefit fairly compensates the service-disabled veterans and their families. 

   The Commission identified 14 priority recommendations, among them:

  • Using an updated VA Schedule for Rating Disabilities (VASRD) that would include the evaluation and rating of posttraumatic stress disorder (PTSD) and other mental disorders and of traumatic brain injury (TBI) in both the DoD and VA and would be revised to account for new diagnostic classifications, medical criteria and medical advances;
  • Identifying specific criteria for PTSD rating and establishing a holistic approach to PTSD that couples compensation, treatment, and vocational assessment. Re-evaluation should occur every 2-3 years to ensure that treatment is effective;
  • Initially increasing compensation rates up to 25 percent to take into account the quality of life and other non-work related effects of severe disabilities on veterans and their families;
  • Eliminating the ban on concurrent receipt for all military retirees and for all service members who are separated from the military due to service-connected disabilities, as well as eliminating the SBP/DIC offset for survivors of retirees and in-service deaths, with priority for the more severely disabled veterans.
  • Expediting compatible information systems for VA and DoD;
  • Realigning the disability evaluation process so that the Military Services determine fitness for duty and service members who are found unfit for duty are referred to VA for disability rating;
  • Improving the claims cycle by establishing a simplified and expedited process using best practices and maximizing use of information technology.
During the course of its comprehensive investigation, the Commission conducted eight fact-finding site visits throughout the country and heard from thousands of veterans, advocates and family members regarding the current veterans’ disability system. In addition, the Commission employed the Institute of Medicine to review the medical and functional criteria used to rate impairments and other related areas and the CNAC Corporation to provide an overall analysis of the disability and survivors benefits.

The Veterans’ Disability Benefits Commission is an independent, bipartisan body created by Public Law 108-136 and appointed by the President and leaders of Congress, mandated to study the benefits and services intended to compensate and assist veterans and their survivors for disabilities and deaths attributable to military service. The Commission examined the full range of programs that are intended to meet the needs of disabled veterans and survivors.

The Department of Veterans Affairs (VA) announced that the Audie L. Murphy Memorial Veterans Hospital in San Antonio will house the nation’s newest Polytrauma Rehabilitation Center, where seriously injured and wounded veterans can go to receive intensive medical rehabilitation for treatment of disabilities due to trauma.

VA created four special TBI centers in 1992 in Minneapolis, Minn.; Richmond, Va.; Tampa, Fla.; and Palo Alto, Calif.  The centers expanded their mission in recent years to assist TBI patients and service members suffering from other serious problems, including amputations, burns, blindness and post-traumatic stress disorders (PTSD). Their new designation as polytrauma centers reflects their expanded mission.  The facilities have structured their services around teams of specialists.

Last year, the four polytrauma centers were joined by 17 other regionally-based facilities to meet the needs of less severely injured veterans or those whose conditions had stabilized at one of the four primary polytrauma centers.

The San Antonio project will consist of two stages.  In the first, VA will construct an 84,000 square-foot, three-level building for rehabilitation, transitional living and prosthetics.  This will be followed by renovation of 32,500 square feet of office and exam room spaces in the main medical center building at the veterans medical center.

The cost of the entire project is estimated at $66 million.  Construction is expected to begin next year. http://www1.va.gov/opa/pressrel/pressrelease.cfm?id=1389 

Back to Top

Health Care News

The National Institutes of Health (NIH) is launching one of the most extensive collections of genetic and clinical data ever made freely available to researchers worldwide. Called SHARe (SNP Health Association Resource), the Web-based dataset enables qualified researchers to access a wealth of data from large population-based studies, starting with the landmark Framingham Heart Study. Funded by the NIH's National Heart, Lung, and Blood Institute (NHLBI), SHARe will accelerate discoveries linking genes and health, thereby advancing scientists' understanding of the causes and prevention of cardiovascular disease and other disorders.

Framingham SHARe includes data on more than 9,300 participants spanning three generations, including over 900 families, who had their DNA tested for 550,000 genetic variations (single nucleotide polymorphisms, or SNPs). In addition, the participants' clinical data gathered during the study, such as test results or weight, are included. SHARe will enable researchers to relate study participants' genetic variations with their clinical and laboratory test results. The Framingham Heart Study is funded by NHLBI in collaboration with Boston University School of Medicine (BUSM) and Boston University School of Public Health.

SHARe is accessed through dbGaP, or the database of Genotypes and Phenotypes, a Web-based resource for archiving and distributing data from genome-wide association studies (GWAS). GWAS explore the associations between genes and observable traits, such as weight, cholesterol levels, or the presence or absence of a disease. Launched in December 2006, dbGaP was developed and is operated by the National Center for Biotechnology Information (NCBI), a division of NIH's National Library of Medicine (NLM).

Researchers interested in applying for access to individual-level Framingham SHARe data should follow the directions at http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?id=phs000007. http://www.nih.gov/news/pr/oct2007/nhlbi-01.htm

The Substance Abuse and Mental Health Services Administration announced the award of 67 grants totaling nearly $159 million over five years to provide coordinated substance abuse treatment and HIV/AIDS services targeting African American, Hispanic, and other racial or ethnic minority communities affected by the epidemics of substance abuse and HIV/AIDS.

All of the grantees will offer rapid HIV testing, through on-site testing or by referral to a licensed partner agency or health department. Along with substance abuse treatment and HIV counseling and testing, Targeted Capacity Expansion Program projects offer health education, referrals, case management, and testing for sexually transmitted infections, hepatitis and tuberculosis. In addition, the program funds outreach and pretreatment for people living with or at risk for HIV/AIDS related to their substance abuse.

The 67 awards under the Targeted Capacity Expansion Program for Substance Abuse Treatment and HIV/AIDS Services are funded up to $500,000 per year in total costs for treatment services and $400,000 annually for outreach and treatment services. Continuation of these awards is subject to the availability of funds, as well as the progress achieved by the grantees. Total funding for year one is $31.8 million. To view the list of grantees please visit: http://www.samhsa.gov/newsroom/advisories/0710035724.aspx

The U.S. Food and Drug Administration approved Afluria, an additional seasonal influenza vaccine for the immunization of people ages 18 and older.  Afluria, manufactured by CSL Limited of Parkville, Australia, is intended to protect adults from influenza type A and type B flu viruses.  Influenza is a contagious respiratory illness that can cause annual epidemics.

Based on current manufacturing trends, the Centers for Disease Control and Prevention estimates that the six manufacturers will supply a record 132 million doses of influenza vaccine for the 2007-2008 influenza season.

Afluria was approved using FDA's accelerated approval pathway for serious or life-threatening diseases, which reduces the time for needed medical products to become available to the public. In this case, the manufacturer demonstrated that the vaccine induced levels of antibodies in the blood likely to be effective in preventing seasonal influenza. As part of the accelerated approval process, the manufacturer will conduct further studies to verify that the vaccine decreases seasonal influenza disease after vaccination. 

The vaccine is administered as a single injection in the upper arm, and is available in both a single-dose, preservative-free, pre-filled syringe and a multi-dose vial with thimerosal, a mercury derivative, as a preservative.  http://www.fda.gov/bbs/topics/NEWS/2007/NEW01714.html

The U.S. Food and Drug Administration launched a program aimed at increasing the number and variety of generic drug products available to consumers and health care providers. Generic drugs generally cost less than their brand-name counterparts and competition among generics has been a key factor in lowering drug prices. The Generic Initiative for Value and Efficiency, or GIVE, will help the FDA modernize and streamline its generic drug approval process.

The agency approved or tentatively approved a record of 682 generic drugs products in fiscal year 2007, an increase of  more than 30 percent from the previous year.

As part of the GIVE efforts, FDA is revising the review order for certain drug applications. For example, first generic products, for which there are no blocking patents or exclusivity protections on the reference listed drug, are identified at the time of submission for expedited review. This will mean that these products, for which there are currently no generic products on the market, may reach the consumer much faster.

Generic drugs undergo a rigorous scientific review to ensure that they are of high quality, safe, and effective. Generic drug manufacturers must demonstrate that a generic drug has the same dosage form, strength, route of administration, and conditions of use as the approved brand-name product. They also must demonstrate bioequivalence, meaning that the drug delivers the same amount of its active ingredient in the same amount of time as the brand-name counterpart. Bioequivalence is a critical requirement for concluding that the original and generic drugs will produce the same therapeutic results.  http://www.fda.gov/bbs/topics/NEWS/2007/NEW01719.html 

Back to Top

Reserve/Guard

The total number of Guard and Reserve currently on active duty has decreased by 3,996 from the last report to 91,409. The totals for each service are Army National Guard and Army Reserve, 70,758; Navy Reserve, 5,727; Air National Guard and Air Force Reserve, 7,831; Marine Corps Reserve, 6,812; and the Coast Guard Reserve, 281. www.defenselink.mil

Back to Top

Reports/Policies

The GAO issued “Influenza Pandemic: Federal Executive Boards' Ability to Contribute to Pandemic Preparedness,” (GAO-07-1259T) on Sept. 28, 2007.  http://www.gao.gov/new.items/d071259t.pdf

The Institute of Medicine released “Improving the Presumptive Disability Decision-Making Process for Veterans,” on Oct. 3, 2007. The report examined the current system and concluded that the presumptive disability decision-making process should be based on evidence about military exposures and veterans’ health and if a specific health condition for a specified group of veterans was at least as likely as not to have been caused by their military service. IOM proposed a framework for the future that will be based on findings about the health of veterans that come from tracking of exposures during military service as well as tracking of health status at entry into, during, at separation from and after military service.  http://www.iom.edu/CMS/26761/34756/45306.aspx

The GAO released “Global Health: U.S. Agencies Support Programs to Build Overseas Capacity for Infectious Disease Surveillance,” (GAO-07-1186) on Oct. 4, 2007.  The report, published on Sept. 28, 2007, examines the obligations, goals, and activities of programs run by the Centers for Disease Control and Prevention, the U.S. Agency for International Development, and the Department of Defense and the agencies' monitoring of the programs' progress. http://www.gao.gov/new.items/d071186.pdf

Back to Top

Legislation

H.J.RES.54 (introduced Sept. 27, 2007): Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Centers for Medicare & Medicaid Services within the Department of Health and Human Services relating to Medicare coverage for the use of erythropoiesis stimulating agents in cancer and related neoplastic conditions was referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. 
Sponsor: Representative Anna G. Eshoo [CA-14]

H.R.3681 (introduced Sept. 27, 2007): To amend title 38, United States Code, to authorize the Secretary of Veterans Affairs to advertise in the national media to promote awareness of benefits under laws administered by the Secretary was referred to the House Committee on Veterans' Affairs. 
Sponsor: Representative John Boozman [AR-3]

H.R.3689 (introduced Sept. 27, 2007): To amend the Public Health Service Act to authorize the Director of the National Cancer Institute to make grants for the discovery and validation of biomarkers for use in risk stratification for, and the early detection and screening of, ovarian cancer was referred to the House Committee on Energy and Commerce. 
Sponsor: Representative Howard L. Berman [CA-28]

H.R.3697 (introduced Sept. 27, 2007): To amend the Public Health Service Act to address antimicrobial resistance was referred to the House Committee on Energy and Commerce. 
Sponsor: Representative Jim Matheson [UT-2]

H.R.3701 (introduced Sept. 27, 2007): To amend the Public Health Service Act to direct the Secretary of Health and Human Services to intensify programs with respect to research and related activities concerning falls among older adults was referred to the House Committee on Energy and Commerce. 
Sponsor: Representative Frank Pallone, Jr. [NJ-6]

H.R.3710 (introduced Oct. 1, 2007): To amend the Public Health Service Act to establish an Office of Correctional Public Health was referred to the House Committee on Energy and Commerce. 
Sponsor: Representative Tim Holden [PA-17]

S.RES.335 (introduced Sept.27, 2007): A resolution recognizing that the occurrence of prostate cancer in African American men has reached epidemic proportions and urging Federal agencies to address that health crisis by designating funds for education, awareness outreach, and research specifically focused on how that disease affects African American men was referred to the Committee on Health, Education, Labor, and Pensions. 
Sponsor: Senator John F. Kerry [MA]

S.2105 (introduced Sept.27, 2007): A bill to provide for the establishment of the Federal Health Care Board was referred to the Committee on Health, Education, Labor, and Pensions. 
Sponsor: Senator Chuck Hagel [NE]

S.2108 (introduced Sept.27, 2007): A bill to establish a public education and awareness program relating to emergency contraception was referred to the Committee on Health, Education, Labor, and Pensions. 
Sponsor: Senator Patty Murray [WA]

S.AMDT.3089 to H.R.1585 (introduced Sept.27, 2007): To provide for a continuation of transitional health benefits for members of the Armed Forces pending a resolution of their service-related medical conditions was agreed to in the Senate by Unanimous Consent.  
Sponsor: Senator John McCain [AZ]

Back to Top

Hill Hearings

The House Veterans Affairs Subcommittee on Disability Assistance and Memorial Affairs will hold a field hearing on Oct. 9, 2007, to examine the personal costs of the VA claims backlog.

The House Veterans Affairs Committee will hold a hearing on Oct. 10, 2007, to examine the findings of the Veterans Disability Benefits Commission.

The Senate Veterans Affairs Committee will hold a hearing on Oct. 17, 2007, to examine Departments of Veterans Affairs and Defense collaboration, focusing on the report of the President's Commission on Care for America's Returning Wounded Warriors, the report of the Veterans Disability Benefit Commission, and other related reports.

The House Veterans Subcommittee on Health will held a hearing on Oct. 18, 2007, to examine the impact of health care on recruitment and retention.

The Senate Veterans Affairs Committee will hold a hearing on Oct. 24, 2007, to consider pending legislation.

The Senate Veterans Affairs Committee will hold a hearing on Oct. 31 2007, to examine vocational rehabilitation. 

Back to Top

Meetings / Conferences

The Food and Drug Administration (FDA) will hold a public meeting on Oct. 19, 2007, to solicit views and information from interested persons on issues concerning how the agency can best plan and apply information technology (IT) resources to support the process for the review of human drug applications. Federal Register Notice

The 20th Annual Infectious Diseases in Children Symposium will be held on Oct. 20-21, 2007, in New York City, N.Y. http://www.vindicomeded.com/meetings/idc/ny/default.htm

The National Cancer Institute (NCI), will hold a symposium: “HIV/AIDS Research at the National Cancer Institute: a Record of Sustained Excellence,” on Nov. 1- 2, 2007, in Bethesda Md. http://web.ncifcrf.gov/events/hivaidsresearch2007

The American Association for Clinical Chemistry (AACC) and the National Academy of Clinical Biochemistry (NACB) will hold a one-day conference: “Making the Case for the New Cancer Diagnostics,” on Nov. 2, 2007, in St. Louis, Mo.  http://www.aacc.org/AACC/events/meetings/NewCancerDetectionTechnologies.htm

The 46th Annual Research in Medical Education (RIME) Conference will be held Nov. 2-7, 2007, in conjunction with the AAMC Annual Meeting in Washington, D.C. http://www.aamc.org/meetings/annual/2007/start.htm

The American Public Health Association 135th Annual Meeting will be held on Nov. 3-7, 2007, in Washington, D.C. http://apha.confex.com/apha/135am/techprogram/

The FDA’s conference: “Anthrax Vaccines -- Bridging Correlates of Protection in Animals to Immunogenicity in Humans,” will be held on Nov. 8-9, 2007, in Gaithersburg Md. http://www.fda.gov/OHRMS/DOCKETS/98fr/E7-11613.htm

The AMSUS 113th Annual Meeting will be held Nov. 11-16, 2007, in Salt Lake City, Utah.  http://www.amsus.org/convention/

The 27th AMEDD Neurology Meeting will be held on Nov. 14-16, 2007, in Washington, D.C.  www.hjf.org/events

The 2007 meeting of the Army and Air Force Chapters of the ACP will be held on Nov. 14-18, 2007, in San Antonio, Texas.  www.hjf.org/events

The 47th ASCB Annual Meeting will be held on Dec. 1-5, 2007, in Washington D.C. http://www.ascb.org/meetings/

The Special Operations Medical Conference will be held on Dec. 10-13, 2007, in Tampa, Fla. https://www.trueresearch.org/soma/2007/attendee-registration.aspx

The State of the MHS - The 2008 Annual TRICARE Conference will be held on Jan. 28-31, 2008, in Washington D.C. http://www.tricare.mil/conferences.cfm

The American Medical Directors' Association's (AMDA) 2008 Annual Symposium will beheld on March 6-9, 2008, in Salt Lake City, Utah. http://www.amda.com/education/annsym08/

The 5th Annual World Healthcare Congress will be held on April 21-23, 2008,, in Washington D.C.
http://www.worldcongress.com/email/HR08000/HR08000-9-11-07Online.htm

The 13th International Congress on Infectious Diseases will be held June 19-22, 2008, in Kuala Lumpur, Malaysia.  http://www.isid.org/13th_icid/

Back to Top


If you need further information on any of the items in the Federal Health Update, please contact Kate Connelly Theroux at (703) 447-3257 or by e-mail at kate@usminstitute.org. To subscribe, please visit http://usminstitute.org/subscriber.cfm. To unsubscribe, please send an email to update@usminstitute.org with UNSUBSCRIBE as the subject.

© Copyright 2007, U.S. Medicine Institute
5185 MacArthur Blvd. NW, Suite 104-656, Washington, DC 20016
(202)271-5814 info@usminstitute.org